WCN26-2543 PARAMETER-KINETICS OF APOPTOSIS INHIBITOR OF MACROPHAGE (AIM) IN CONTRAST-ASSOCIATED ACUTE KIDNEY INJURY: A PILOT STUDY

Read full text Summarise with VIRAT
Authors: Yoko Nishizawa, Satoshi Miyata, Ryosuke Usui, Eriko Hirasawa, Nozomiko Okuda, Yuki Kawahara, Eiji Shibahashi, Kentaro Jujo, Akimi Nishijima, Toru Miyazaki, Junichi Hoshino, Tetsuya Ogawa
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Contrast-induced acute kidney injury (CA-AKI) is one of the major causes for AKI. To diagnose CA-AKI, we use serum creatinine (SCr), however, its slow kinetics makes it difficult to diagnose it in earlier stage. In contrast, serum kidney injury molecule-1 (KIM-1) is reported as one of the earlier biomarkers for CA-AKI. KIM-1 collaborates with apoptosis inhibitor of macrophage (AIM) to help recovering from AKI. Our study objective is to describe AIM kinetics in CA-AKI high-risk patients undergoing angiography (AG).

Fields of Study & Subjects

Acute Kidney Injury Research Chronic Kidney Disease and Diabetes Chemotherapy-induced organ toxicity mitigation

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
103950–103950
Publication date
25 March 2026
Language
EN